Randomized controlled phase III trial of adjuvant chemoimmunotherapy with activated cytotoxic T cells and dendritic cells from regional lymph nodes of patients with lung cancer.

Kimura, Hideki; Matsui, Yukiko; Ishikawa, Aki; Nakajima, Takahiro; Iizasa, Toshihiko

Kimura, Hideki; Matsui, Yukiko; Ishikawa, Aki; Nakajima, Takahiro; Iizasa, Toshihiko.

Affiliation

Kimura H; Department of Thoracic Surgery, Saiseikai-Narashino Hospital, Izumi-cho 1-1-1, Narashino, Chiba, 275-8580, Japan. h.kimura1028@seikeikai-cmc.jp.
Matsui Y; Department of Thoracic Surgery, Chiba Cancer Center, Chiba, Japan.
Ishikawa A; Department of General Thoracic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
Nakajima T; Department of General Thoracic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
Iizasa T; Department of Thoracic Surgery, Chiba Cancer Center, Chiba, Japan.

Cancer Immunol Immunother ; 67(8): 1231-1238, 2018 08.

Article in En | MEDLINE | ID: mdl-29855695

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carcinoma, Non-Small-Cell Lung/therapy; Dendritic Cells/immunology; Immunotherapy; Lung Neoplasms/therapy; Lymph Nodes/immunology; T-Lymphocytes, Cytotoxic/immunology; Adenocarcinoma/immunology; Adenocarcinoma/pathology; Adenocarcinoma/therapy; Aged; Carcinoma, Non-Small-Cell Lung/immunology; Carcinoma, Non-Small-Cell Lung/pathology; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Lung Neoplasms/immunology; Lung Neoplasms/pathology; Male; Middle Aged; Neoplasm Recurrence, Local/immunology; Neoplasm Recurrence, Local/pathology; Neoplasm Recurrence, Local/therapy; Prognosis; Survival Rate

Key words

Adjuvant therapy; Cellular immunotherapy; Cytotoxic T cells; Lung cancer; Regional lymph nodes

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dendritic Cells / T-Lymphocytes, Cytotoxic / Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Non-Small-Cell Lung / Immunotherapy / Lung Neoplasms / Lymph Nodes Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2018 Document type: Article Affiliation country: Japan Country of publication: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google